ANRO
ANRO
NYSE · Pharmaceuticals

Alto Neuroscience Inc

$26.18
+1.74 (+7.12%)
Analyst Consensus
Strong Buy
18
Analysts
High
Coverage
Buy 16 89%
Hold 2 11%
Sell 0 0%
Price Target
Analyst Price Target -15.3% upside
Low Target $14.63
Average Target $22.17
High Target $27.87
Current Price $26.18
Current
$26.18
Target
$22.17
$14.63 $22.17 avg $27.87
Scenario Analysis
Bear Case
$14.63
-44.1%
Low target
Base Case
$22.17
-15.3%
Avg target
Bull Case
$27.87
+6.5%
High target
Risk/Reward
0.1x
Unfavorable
Price in Context
52-Week High
$28.44
-7.9% from high
52-Week Low
$2.15
+1,117.7% from low
Target vs 52W High
$22.17
-22.0% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 39 79% $1,330.33 +20.2%
RDY
Dr. Reddy's Laboratories
Sell 44 50% +0.0%
JNJ
Johnson & Johnson
Buy 31 68% $299.55 +25.3%
MRK
Merck & Co. Inc.
Buy 36 69% $159.27 +33.2%
PFE
Pfizer Inc.
Hold 36 42% $33.90 +37.1%
BMY
Bristol-Myers Squibb Co
Hold 36 39% $174.50 +214.2%
ZTS
Zoetis Inc
Buy 24 58% $209.87 +173.1%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -34.5%